Which type of patients with asymptomatic peripheral arterial disease with an ABI score of less than 0.9, is it reasonable to offer antiplatelet and statin therapy to?
Answer from: at Academic Institution
This is an important question. Unfortunately, there is no good evidence to help answer it. So what I am about to say is not evidence-based, but it is common sense. Since patients with PAD have an increased rate of MI, Stroke, and CV death, they should all receive maximum medical therapy. I believe t...
Comments
at The George Washington University Hospital Agree with statin; ASA, Clopidigrel, DOAC depends ...
More information is needed. Why were ABIs obtained if the patient is asymptomatic? How old is the patient and what are the patient's CVD risk factors?
I agree that a statin is reasonable for most patients under age 75 with asymptomatic PAD. For those age 75 or older, shared decision-making wo...
Agree with statin; ASA, Clopidigrel, DOAC depends ...